| IMMUNE SYSTEM KEY LTD. Patent applications |
| Patent application number | Title | Published |
|---|
| 20100204097 | THERAPEUTIC METHODS USING A THYMUS PEPTIDE - A method for treating or preventing a disease involving a cell having a T1/ST2 receptor, including administering to subject in need thereof a therapeutically effective amount of a thymic peptide, is provided. Also provided is a method for inhibiting the pathological effects of activated monocytes in a subject in need thereof including treating the monocytes with an effective amount of the thymic peptide. | 08-12-2010 |
| 20090018060 | Thymus-specific protein - The invention provides the novel thymus-specific human protein T101, an 84-amino acid polypeptide isolated from the human thymus. The full T101 peptide contains a 33-amino acid signal peptide and a 51-amino acid T101 peptide sequence with both immune stimulatory and inhibitory activities. Also provided are modified peptides and partial T101 peptide sequences. | 01-15-2009 |
